Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Nov. 02, 2019	Nov. 03, 2018
OPERATING ACTIVITIES:
Net loss	$ (37,908)	$ (12,183)
Adjustments to reconcile net loss to net cash (used for) provided by operating activities:
Depreciation and amortization	9,192	7,667
Share-based payment compensation	1,683	2,180
Inventory impairment write-down	6,050	0
Amortization of deferred revenue	27	27
Amortization of deferred financing costs	152	159
Changes in operating assets and liabilities:
Accounts receivable, net	18,034	22,417
Inventories	(23,577)	(17,197)
Prepaid expenses and other	640	(2,841)
Accounts payable and accrued liabilities	23,006	10,969
Net cash (used for) provided by operating activities	(2,755)	11,144
INVESTING ACTIVITIES:
Property and equipment additions	(5,367)	(6,681)
Net cash used for investing activities	(5,367)	(6,681)
FINANCING ACTIVITIES:
Proceeds from issuance of revolving loan	160,400	177,100
Proceeds from issuance of common stock and warrants	6,000	0
Proceeds of term loan	0	5,821
Proceeds from exercise of stock options	0	181
Payments on revolving loan	(160,400)	(186,100)
Payments on term loan	(2,035)	(1,647)
Payments for common stock issuance costs	(109)	0
Payments on finance leases	(46)	(4)
Payments for restricted stock issuance	(21)	(130)
Payments for deferred financing costs	0	(96)
Net cash provided by (used for) financing activities	3,789	(4,875)
Net decrease in cash and restricted cash equivalents	(4,333)	(412)
BEGINNING CASH AND RESTRICTED CASH EQUIVALENTS	20,935	24,390
ENDING CASH AND RESTRICTED CASH EQUIVALENTS	16,602	23,978
SUPPLEMENTAL CASH FLOW INFORMATION:
Interest paid	2,288	2,386
Income taxes paid	31	14
SUPPLEMENTAL NON-CASH INVESTING AND FINANCING ACTIVITIES:
Property and equipment purchases included in accounts payable	387	1,026
Equipment acquired through finance lease obligations	188	30
Issuance of warrants	$ 193	$ 0